Physician profile
Kayla Walker
NPI 1831863463
$4,257.92
in general payments reported to CMS, 2019-2025
26 companies · $2,299 in 2025
The $2,299 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $702 · 2024: $1,257 · 2025: $2,299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,257.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $832.75 | 2023-2025 | Breztri, Farxiga, Airsupra |
| Axsome Therapeutics, INC. | $523.54 | 2024-2025 | Auvelity |
| Lilly USA, LLC | $491.04 | 2023-2025 | Mounjaro, Zepbound, Trulicity |
| Abbvie INC. | $384.52 | 2023-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $318.10 | 2023-2025 | Trintellix |
| Novo Nordisk INC | $313.99 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $217.19 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $182.35 | 2023-2025 | Rexulti, Abilify Maintena |
| Glaxosmithkline, LLC. | $166.44 | 2023-2025 | Shingrix, Bexsero, Pediarix |
| Dexcom, INC. | $163.29 | 2024-2025 | Dexcom G6 Transmitter |
| Lundbeck LLC | $123.42 | 2023-2025 | Rexulti |
| Astellas Pharma US INC | $59.98 | 2025 | Veozah |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $53.36 | 2024-2025 | Caplyta |
| Globus Medical, INC. | $51.76 | 2025 | Senza |
| Eisai INC. | $49.57 | 2023-2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $47.29 | 2023-2024 | Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.59 | 2023-2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $42.84 | 2025 | |
| Exact Sciences Corporation | $41.13 | 2023-2025 | Cologuard Collection Kit |
| Viatris Specialty LLC | $35.69 | 2025 | Yupelri |
| Merck Sharp & Dohme LLC | $29.01 | 2023-2024 | Gardasil 9, Vaxelis, Rotateq |
| Inspire Medical Systems, INC. | $18.73 | 2025 | Inspire |
| Phathom Pharmaceuticals, INC. | $18.13 | 2024 | Voquezna |
| Boston Scientific Corporation | $17.89 | 2025 | Axonics |
| Medtronic, INC. | $16.24 | 2024 | Intellis Adaptivestim |
| Kowa Pharmaceuticals America, INC. | $14.08 | 2023 | Seglentis, Livalo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kayla Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.